Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
europe blog main
europe top stories
2
×
fda
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
2
×
seattle blog main
seattle top stories
texas blog main
texas top stories
2
×
wisconsin blog main
wisconsin top stories
accent therapeutics
aducanumab
alzheimer's disease
amblyotech
arena pharmaceuticals
asklepios biopharmaceutical
bioeurope
biogen
biomarin pharmaceutical
What
fda
2
×
activity
approvals
bio
biogen
cancer
clamped
covid
delays
developing
drug
economic
eisai
fast
flags
higher
incidence
including
ipo
isn’t
lorcaserin
loss
lot
market
marketing
medicine
medicines
new
oric’s
patients
post
pulls
risks
roundup
showing
spread
study
testing
took
weight
Language
unset
Current search:
photo
×
fda
×
" san francisco top stories "
×
" europe top stories "
×
" texas top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks